摘要
目的探讨银杏达莫注射液治疗椎-基底动脉供血不足(V-BAI)的临床疗效。方法将116例V-BAI的患者随机分为两组,研究组66例,银杏达莫注射液20ml加入0.9%氯化钠注射液250ml静脉点滴,每日1次;对照组50例,复方丹参注射液20ml加入0.9%氯化钠注射液250ml静脉点滴,每日1次。疗程均2周。结果研究组症状完全缓解53例,明显好转6例,轻度缓解4例,无效3例;对照组症状完全缓解5例,明显好转18例,轻度缓解16例,无效11例。研究组总显效率为95.45%,明显高于对照组的78%(P<0.01)。结论银杏达莫注射液治疗椎-基底动脉供血不足疗效显著,安全可靠。
Objective To explore the clinical effect of rreating the ischemia of vertebral-basilar arteries by venous infusion of Yinxingdamo. Methods 116 cases of the patients suffering from the ischemia of vertebral-basilar arteries were divided randomly into two groups. In study group, 66 patients were infused 20ml of Yinxingdamo injection added in 0.9 % NS 250ml by I.V.q.d. for two weeks. In controlled group 50 patients were infused 20ml of compound danshen injection in 250m1 0.9 % NS by I. V q.d. for two weeks. Results In study group, the symptoms of 55 cases were completely remissive,6 cases significantly improved,4 cases mildly improved, and no improvement was found in one case. In controlled group, the symptoms of 5 cases were completely remissive, 18 cases significantly improved, 16 eases mildly improved, and no improvement was found in 11 cases. In study group the total efficacy rate of 98.48 % was significantly higher than that of controlled group which was 78 % (P 〈 0.01). Conclusion Venous infusion of Yinxingdamo to treat the ischemia of vertebral-basilar arteries is clinically significantly effective and safe.
出处
《中国基层医药》
CAS
2006年第1期120-121,共2页
Chinese Journal of Primary Medicine and Pharmacy